Clothing & Shoes
Dr Martens downgrades FY guidance amid higher costs
According to the retailer, it maintains FY24 revenue growth guidance of mid to high single digits on a constant currency basis
Dr Martens has downgraded the groupโs FY23 guidance with EBITDA now expected to be around ยฃ245m due to higher costs at its US stores and lower wholesale revenue.ย
You'll need to
subscribe to unlock this content. Already subscribed? Login?